Mach7 Technologies Limited (TDMMF) Q2 2026 Earnings Call January 29, 2026 5:30 PM EST

Company Participants

Francoise Dixon - Head of Investor Relations Teri Thomas - CEO, MD & Director Daniel Lee - Chief Financial Officer

Presentation

Francoise Dixon Head of Investor Relations

And welcome to the Mach7 Q2 FY ’26 Results Briefing. My name is Francoise Dixon, and I’m Head of Investor Relations for Mach7. Today, our CEO, Teri Thomas; and our CFO, Daniel Lee, will provide an overview of our Q2 FY ’26 results. We will then open it up for questions. If you have a question, please submit it by the Q&A text box at the bottom of the screen. I’ll now hand over to Teri.

Teri Thomas CEO, MD & Director

Thank you, Francoise. All right. Before I speak about the quarter, I want to briefly ground everyone in who we are and what we do, particularly for those who are newer to Mach7. So we complete the patient’s picture with the patient’s pictures. We get the right medical images to the right people in the right places at the right time. We do it fast and with diagnostic quality.

We operate in a growing and important industry. And in my frequent conversations with our customers, I’m reminded regularly just how mission-critical our work is. While the health care industry has seen pretty solid progress organizing text-based clinical data over the years, imaging data, which goes far beyond x-rays, remains quite fragmented. Many types of images are locked in proprietary systems spread across multiple departments, stored in lots of different formats, and that causes fragmentation.

That fragmentation represents opportunity and this opportunity Mach7 is well positioned to address. So our ambition is for Mach7 to become the world’s imaging EMR. That ambition, big, it underpins our strategy of moving from archive to